Evidence map›Paper›PMID 40691262›Full record

ArticleScientific reports2025

Nanopore full length 16S rRNA gene sequencing increases species resolution in bacterial biomarker discovery.

Pablo Aja-Macaya, Kelly Conde-Pérez, Noelia Trigo-Tasende, Elena Buetas, Mohammed Nasser-Ali, Paula Nión, Soraya Rumbo-Feal, Susana Ladra, Germán Bou, Álex Mira and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Sentinel plants enable quantitative monitoring of bioavailable nitrate in soils and microbial environments.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Pablo Aja-Macaya *Grupo de Investigación en Microbiología, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complejo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade de A Coruña (UDC), As Xubias, 15006, A Coruña, Galicia, Spain.
Kelly Conde-Pérez *Grupo de Investigación en Microbiología, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complejo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade de A Coruña (UDC), As Xubias, 15006, A Coruña, Galicia, Spain.
Noelia Trigo-Tasende *Grupo de Investigación en Microbiología, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complejo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade de A Coruña (UDC), As Xubias, 15006, A Coruña, Galicia, Spain.
Elena BuetasGenomic and Health Department, FISABIO Foundation, Center for Advanced Research in Public Health, Benimaclet, 46020, Valencia, Comunidad Valenciana, Spain.
Mohammed Nasser-AliGrupo de Investigación en Microbiología, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complejo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade de A Coruña (UDC), As Xubias, 15006, A Coruña, Galicia, Spain.
Paula NiónGrupo de Investigación en Microbiología, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complejo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade de A Coruña (UDC), As Xubias, 15006, A Coruña, Galicia, Spain.
Soraya Rumbo-FealGrupo de Investigación en Microbiología, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complejo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade de A Coruña (UDC), As Xubias, 15006, A Coruña, Galicia, Spain.
Susana LadraDatabase Laboratory (LBD), CITIC, Universidade da Coruña (UDC), Campus de Elviña, 15071, A Coruña, Galicia, Spain.
Germán BouGrupo de Investigación en Microbiología, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complejo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade de A Coruña (UDC), As Xubias, 15006, A Coruña, Galicia, Spain.
Álex MiraGenomic and Health Department, FISABIO Foundation, Center for Advanced Research in Public Health, Benimaclet, 46020, Valencia, Comunidad Valenciana, Spain.
Juan A VallejoGrupo de Investigación en Microbiología, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complejo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade de A Coruña (UDC), As Xubias, 15006, A Coruña, Galicia, Spain. juan.andres.vallejo.vidal@sergas.es.
Margarita PozaGrupo de Investigación en Microbiología, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complejo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade de A Coruña (UDC), As Xubias, 15006, A Coruña, Galicia, Spain.

Funding

CIBERINFEC, Instituto de Salud Carlos III (ISCIII) CB21/13/00055Instituto de Salud Carlos III (ISCIII) PI20/00413Spanish Ministry of Science and Innovation RTI2018-102032-B-I00Spanish Ministry of Science and Innovation-Autonomous Community of Galicia PRTR-C17.I1Xunta de Galicia (Spain) IN607A2024/09
6 · The paper itself

Abstract

Discovery of disease-related bacterial biomarkers could be a useful approach for early prevention or diagnosis of various afflictions, such as colorectal cancer. This typically involves analyzing small regions of the 16S rRNA gene (e.g. V3V4) through short-read technologies like Illumina, obtaining genus-level results. However, recent developments in third-generation sequencing, such as Oxford Nanopore Technologies (ONT)'s new R10.4.1 chemistry and its improved basecalling models, are beginning to allow for a more complete and accessible species-level analysis through full-length 16S rRNA gene sequencing (spanning regions V1-V9). Thus, the goal of this study was to compare and evaluate both approaches, using colorectal cancer biomarker discovery as a representative case. This was achieved through the analysis of feces from 123 subjects, comparing both methods (Illumina-V3V4 with DADA2 and QIIME2 vs. ONT-V1V9 with Emu), multiple Dorado basecalling models (fast, hac and sup) and multiple databases (SILVA vs. Emu's Default database). Basecalling models broadly resulted in similar taxonomic output, but had significantly higher observed species and different taxonomic identification the lower the basecalling quality (p-value<0.05). Database choice with Emu influenced the identified species greatly, with Emu's Default database obtaining significantly higher diversity and identified species than SILVA (p-value<0.05). However, it overconfidently classified at times what should be an unknown species as the closest match due to its database structure. Bacterial abundance between Illumina-V3V4 and ONT-V1V9 at the genus level correlated well (R

Indexed as

BacteriaColorectal NeoplasmsNanopore SequencingRNA, Ribosomal, 16SBiomarkersFecesHigh-Throughput Nucleotide SequencingHumansNanoporesBiomarkersRNA, Ribosomal, 16S16S rRNABiomarkersColorectal cancerGut microbiomeIlluminaMetabarcodingOxford NanoporeV1V9

Identifiers

PMID40691262
PMCPMC12280133

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.